Table: begin end state 1 44 cytoplasmic 45 66 transmembrane 67 78 non-cytoplasmic 79 100 transmembrane 101 106 cytoplasmic 107 127 transmembrane 128 136 non-cytoplasmic 137 156 transmembrane 157 162 cytoplasmic 163 185 transmembrane 186 209 non-cytoplasmic 210 231 transmembrane 232 250 cytoplasmic 251 273 transmembrane 274 296 non-cytoplasmic 297 318 transmembrane 319 350 cytoplasmic 351 370 transmembrane 371 383 non-cytoplasmic 384 412 transmembrane 413 428 cytoplasmic 429 448 transmembrane 449 453 non-cytoplasmic
Input: >SM_b20903 MAMADITKANQTRADQKPGAQAGRARTTDENPVKRFFRATEIDTRLLGMVGALIIIWLGF QVMTGGLFDGLFLKPRNLWNLTVQTSSVAVMATGMVLVIVTRNIDLSVGSVLGFCGMIMG VLQAQVLPQYLGLGHPATWAITLACGIAVGGAIGALHGSIIAFLNVPAFIVTLGGLLVWR GATWFVTSGQTVAPMDATFRLMGGGTEGSIGATASWIVGSLACIAIVGAILNSRKQRKRF GFPLRPVWAEYFLSILGCALVLGAVAVANHYYWPVNIARRYADANGIAWPDGGLQISHGI AIPVLVAIVVGIVMTFIATRLRFGRYVFALGGNPEAAELAGIKTRWVTVKIFTLMGVLCA IAAAISTARLNAATNAQGELDELYTIAAAVIGGTSLAGGVGTIAGAMIGALVMQSLQSGM VLLGIDTPFQRIVVGVVLVTAVWLDTVYRARAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server